FDA Approves Sarclisa for Certain Patients with Multiple Myeloma
The drug is approved for newly diagnosed patients not eligible for transplant and is to be used in combination with standard-of-care treatment.
August 16, 2026
Breaking News
Can an Office harassment lawyer negotiate a settlement? |
Why is Jack Bodenstein gaining attention? |
Which 100 Series Dash Mats offer the best fit and protection? |
Is oven repair Ottawa worth it for older electric and gas ovens? |
How often should organizations conduct a cloud penetration test? |
